Carlos Fernandez de Larrea, MD, PhD from the Hospital ClÃnic de Barcelona, Barcelona, Spain discusses the definition of complete remission (CR) in multiple myeloma (MM). The current definiton of CR requires a negative serum and IFE and less than 5% bone marrow plasma cells (BMPCs). However, two-thirds of patients with CR still relapse and the aim is to be able to identify those patients who are really cured.
Recorded at the 2016 World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.